Literature DB >> 29352484

Melatonin ameliorates Aβ42 -induced alteration of βAPP-processing secretases via the melatonin receptor through the Pin1/GSK3β/NF-κB pathway in SH-SY5Y cells.

Vorapin Chinchalongporn1, Mayuri Shukla2, Piyarat Govitrapong1,2.   

Abstract

Melatonin is involved in the physiological regulation of the β-amyloid precursor protein (βAPP)-cleaving secretases which are responsible for generation of the neurotoxic amyloid beta (Aβ) peptide, one of the hallmarks of Alzheimer's disease (AD) pathology. In this study, we aimed to determine the underlying mechanisms of this regulation under pathological conditions. We establish that melatonin prevents Aβ42 -induced downregulation of a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) as well as upregulation of β-site APP-cleaving enzyme 1 (BACE1) and presenilin 1 (PS1) in SH-SY5Y cell cultures. We also demonstrate that the intrinsic mechanisms of the observed effects occurred via regulation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and glycogen synthase kinase (GSK)-3β as melatonin reversed Aβ42 -induced upregulation and nuclear translocation of NF-κBp65 as well as activation of GSK3β via its receptor activation. Furthermore, specific blocking of the NF-κB and GSK3β pathways partially abrogated the Aβ42 -induced reduction in the BACE1 and PS1 levels. In addition, GSK3β blockage affected α-secretase cleavage and modulated nuclear translocation of NF-κB. Importantly, our study for the first time shows that peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) is a crucial target of melatonin. The compromised levels and/or genetic variation of Pin1 are associated with age-dependent tau and Aβ pathologies and neuronal degeneration. Interestingly, melatonin alleviated the Aβ42 -induced reduction of nuclear Pin1 levels and preserved the functional integrity of this isomerase. Our findings illustrate that melatonin attenuates Aβ42 -induced alterations of βAPP-cleaving secretases possibly via the Pin1/GSK3β/NF-κB pathway.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Alzheimer's; GSK3β; NF-κB; Pin1; melatonin; secretase

Mesh:

Substances:

Year:  2018        PMID: 29352484     DOI: 10.1111/jpi.12470

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  9 in total

Review 1.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

Review 2.  Interaction of NF-κB and Wnt/β-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments.

Authors:  Xiao Liu; Kaiyue Wang; Xing Wei; Tian Xie; Bin Lv; Qian Zhou; Xiaoying Wang
Journal:  Neurochem Res       Date:  2021-02-01       Impact factor: 3.996

3.  The Role of NF-κB/NLRP3 Inflammasome Signaling Pathway in Attenuating Pyroptosis by Melatonin Upon Spinal Nerve Ligation Models.

Authors:  Yi-Hao Wang; Xiao Gao; Yu-Ru Tang; Yang Yu; Ming-Jie Sun; Fu-Qiang Chen; Yan Li
Journal:  Neurochem Res       Date:  2021-09-13       Impact factor: 3.996

4.  miR-23b-3p rescues cognition in Alzheimer's disease by reducing tau phosphorylation and apoptosis via GSK-3β signaling pathways.

Authors:  Hailun Jiang; Jianghong Liu; Shuilong Guo; Li Zeng; Zhongdi Cai; Junxia Zhang; Linlin Wang; Zhuorong Li; Rui Liu
Journal:  Mol Ther Nucleic Acids       Date:  2022-04-18       Impact factor: 10.183

5.  Melatonin receptor stimulation by agomelatine prevents Aβ-induced tau phosphorylation and oxidative damage in PC12 cells.

Authors:  Kai Yao; Yong-Fei Zhao; Heng-Bing Zu
Journal:  Drug Des Devel Ther       Date:  2019-01-21       Impact factor: 4.162

Review 6.  Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks.

Authors:  Rüdiger Hardeland
Journal:  Int J Mol Sci       Date:  2019-03-11       Impact factor: 5.923

7.  Computational Studies Applied to Flavonoids against Alzheimer's and Parkinson's Diseases.

Authors:  Alex France M Monteiro; Jéssika De O Viana; Anuraj Nayarisseri; Ernestine N Zondegoumba; Francisco Jaime B Mendonça Junior; Marcus Tullius Scotti; Luciana Scotti
Journal:  Oxid Med Cell Longev       Date:  2018-12-30       Impact factor: 6.543

8.  Osthole-Loaded Nanoemulsion Enhances Brain Target in the Treatment of Alzheimer's Disease via Intranasal Administration.

Authors:  Yilei Song; Xiangyu Wang; Xingrong Wang; Jianze Wang; Qiulian Hao; Jifu Hao; Xueqin Hou
Journal:  Oxid Med Cell Longev       Date:  2021-01-25       Impact factor: 6.543

9.  Design and Synthesis of New Benzo[d]oxazole-Based Derivatives and Their Neuroprotective Effects on β-Amyloid-Induced PC12 Cells.

Authors:  Zheng Liu; Ming Bian; Qian-Qian Ma; Zhuo Zhang; Huan-Huan Du; Cheng-Xi Wei
Journal:  Molecules       Date:  2020-11-18       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.